Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate

BACKGROUND: In human immunodeficiency virus (HIV) treatment, tenofovir alafenamide (TAF) is associated with greater increases in all fasting cholesterol subgroups compared with tenofovir disoproxil fumarate (TDF). Because lipid abnormalities may contribute to cardiovascular morbidity and mortality,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Open Forum Infect Dis
Egile Nagusiak: Huhn, Gregory D, Shamblaw, David J, Baril, Jean-Guy, Hsue, Priscilla Y, Mills, Brittany L, Nguyen-Cleary, Thai, McCallister, Scott, Das, Moupali
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Major Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6954396/
https://ncbi.nlm.nih.gov/pubmed/31950070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz472
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak